{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:10:02Z","timestamp":1791724202001,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.endonu.2016.06.004","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T20:02:06Z","timestamp":1476302526000},"page":"495-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["La paradoja diab\u00e9tica: densidad mineral \u00f3sea y fractura en la diabetes tipo 2"],"prefix":"10.1016","volume":"63","author":[{"given":"Sonsoles","family":"Botella Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Varo Cenarruzabeitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Escalada San Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Calleja Canelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2016.06.004_bib0255","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes","volume":"305","author":"Schwartz","year":"2011","journal-title":"JAMA."},{"key":"10.1016\/j.endonu.2016.06.004_bib0260","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","article-title":"Older women with diabetes have an increased risk of fracture: A prospective study","volume":"86","author":"Schwartz","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0265","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes \u2014 a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.endonu.2016.06.004_bib0270","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc06-0440","article-title":"Prospective study of diabetes and risk of hip fracture: The Nurses\u2019 Health Study","volume":"29","author":"Janghorbani","year":"2006","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endonu.2016.06.004_bib0275","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.endonu.2016.06.004_bib0280","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4065\/mcp.2010.0082","article-title":"Impact of prevalent fractures on quality of life: Baseline results from the global longitudinal study of osteoporosis in women","volume":"85","author":"Adachi","year":"2010","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.endonu.2016.06.004_bib0285","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: Medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos."},{"key":"10.1016\/j.endonu.2016.06.004_bib0290","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00198-014-2676-7","article-title":"Biochemical markers of bone turnover in diabetes patients \u2014 a meta-analysis, and a methodological study on the effects of glucose on bone markers","volume":"25","author":"Starup-Linde","year":"2014","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.endonu.2016.06.004_bib0295","first-page":"7","article-title":"Histomorphometric analysis of the bone tissue in patients with non-insulin-dependent diabetes (DMNID)","volume":"51","author":"Leite Duarte","year":"1996","journal-title":"Revista do Hospital das Clinicas."},{"key":"10.1016\/j.endonu.2016.06.004_bib0300","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2337\/diab.44.7.775","article-title":"Bone loss and bone turnover in diabetes","volume":"44","author":"Krakauer","year":"1995","journal-title":"Diabetes."},{"key":"10.1016\/j.endonu.2016.06.004_bib0305","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.bone.2008.02.006","article-title":"High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis","volume":"42","author":"Wittrant","year":"2008","journal-title":"Bone."},{"key":"10.1016\/j.endonu.2016.06.004_bib0310","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/jc.2007-1270","article-title":"Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes","volume":"93","author":"Yamamoto","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0315","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1507\/endocrj.42.377","article-title":"Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus","volume":"42","author":"Nagasaka","year":"1995","journal-title":"Endocr J."},{"key":"10.1016\/j.endonu.2016.06.004_bib0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/nu4010052","article-title":"Focus on vitamin D, inflammation and type 2 diabetes","volume":"4","author":"Chagas","year":"2012","journal-title":"Nutrients."},{"key":"10.1016\/j.endonu.2016.06.004_bib0325","first-page":"41","article-title":"Vitamina D y funci\u00f3n muscular","volume":"16","author":"Guadalix","year":"2007","journal-title":"REEMO"},{"key":"10.1016\/j.endonu.2016.06.004_bib0330","doi-asserted-by":"crossref","first-page":"b3692","DOI":"10.1136\/bmj.b3692","article-title":"Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials","volume":"339","author":"Bischoff-Ferrari","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.endonu.2016.06.004_bib0335","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/dc12-1188","article-title":"High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: The Rotterdam Study","volume":"36","author":"Oei","year":"2013","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endonu.2016.06.004_bib0340","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jbmr.1898","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats","volume":"28","author":"Ma","year":"2013","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.endonu.2016.06.004_bib0345","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2016.04.001","article-title":"A new stable GIP-Oxyntomodulin hybrid peptide improved bone strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus","volume":"87","author":"Mansur","year":"2016","journal-title":"Bone."},{"key":"10.1016\/j.endonu.2016.06.004_bib0350","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.nutres.2015.12.008","article-title":"A high-fat diet increases body weight and circulating estradiol concentrations but does not improve bone structural properties in ovariectomized mice","volume":"36","author":"Cao","year":"2016","journal-title":"Nutr Res."},{"key":"10.1016\/j.endonu.2016.06.004_bib0355","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00198-016-3506-x","article-title":"Changes in bone mineral density over time by body mass index in the health ABC study","volume":"27","author":"Lloyd","year":"2016","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.endonu.2016.06.004_bib0360","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: A link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J Cardiol."},{"key":"10.1016\/j.endonu.2016.06.004_bib0365","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1210\/jc.2007-2491","article-title":"The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin","volume":"93","author":"Natal","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0370","first-page":"9","article-title":"Obesity and fracture risk","volume":"11","author":"Gonnelli","year":"2014","journal-title":"Clin Cases Miner Bone Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0375","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by Wnt signaling","volume":"116","author":"Krishnan","year":"2006","journal-title":"J Clin Invest."},{"key":"10.1016\/j.endonu.2016.06.004_bib0380","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bone.2013.06.029","article-title":"Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes","volume":"56","author":"Ardawi","year":"2013","journal-title":"Bone."},{"key":"10.1016\/j.endonu.2016.06.004_bib0385","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/jc.2013-2143","article-title":"Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus","volume":"98","author":"Yamamoto","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0390","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2337\/dc12-1691","article-title":"Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels","volume":"36","author":"Morales-Santana","year":"2013","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endonu.2016.06.004_bib0395","doi-asserted-by":"crossref","first-page":"564934","DOI":"10.1155\/2015\/564934","article-title":"Osteoprotegerin in cardiometabolic disorders","volume":"2015","author":"Perez de Ciriza","year":"2015","journal-title":"Int J Endocrinol."},{"key":"10.1016\/j.endonu.2016.06.004_bib0400","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/jc.2002-020775","article-title":"Increased osteoprotegerin serum levels in men with coronary artery disease","volume":"88","author":"Schoppet","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0405","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.clinbiochem.2014.09.004","article-title":"Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification","volume":"47","author":"Perez de Ciriza","year":"2014","journal-title":"Clin Biochem."},{"key":"10.1016\/j.endonu.2016.06.004_bib0410","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bone.2015.04.026","article-title":"Effects of diabetes drugs on the skeleton","volume":"82","author":"Meier","year":"2016","journal-title":"Bone."},{"key":"10.1016\/j.endonu.2016.06.004_bib0415","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2012-4018","article-title":"Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus","volume":"98","author":"Bilezikian","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0420","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11914-010-0027-y","article-title":"Bone loss in diabetes: Use of antidiabetic thiazolidinediones and secondary osteoporosis","volume":"8","author":"Lecka-Czernik","year":"2010","journal-title":"Curr Osteoporos Rep."},{"key":"10.1016\/j.endonu.2016.06.004_bib0425","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(14)70227-X","article-title":"Possible adverse effects of SGLT2 inhibitors on bone","volume":"3","author":"Taylor","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.endonu.2016.06.004_bib0430","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2015.07.025","article-title":"SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA\/2 J male mice","volume":"82","author":"Thrailkill","year":"2016","journal-title":"Bone."},{"key":"10.1016\/j.endonu.2016.06.004_bib0435","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2015-3167","article-title":"Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus","volume":"101","author":"Watts","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0440","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group","volume":"843","year":"1994","journal-title":"World Health Organ Tech Rep Ser."},{"key":"10.1016\/j.endonu.2016.06.004_bib0445","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: A meta-analysis of observational studies","volume":"27","author":"Ma","year":"2012","journal-title":"Eur J Epidemiol."},{"key":"10.1016\/j.endonu.2016.06.004_bib0450","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.endonu.2016.06.004_bib0455","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s00198-014-2822-2","article-title":"Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?","volume":"25","author":"Leslie","year":"2014","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.endonu.2016.06.004_bib0460","doi-asserted-by":"crossref","first-page":"b4229","DOI":"10.1136\/bmj.b4229","article-title":"Predicting risk of osteoporotic fracture in men and women in England and Wales: Prospective derivation and validation of QFractureScores","volume":"339","author":"Hippisley-Cox","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.endonu.2016.06.004_bib0465","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bone.2015.02.019","article-title":"Biochemical bone turnover markers in diabetes mellitus \u2014 A systematic review","volume":"82","author":"Starup-Linde","year":"2016","journal-title":"Bone."},{"key":"10.1016\/j.endonu.2016.06.004_bib0470","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00223-014-9842-y","article-title":"A meta-analysis of reference markers of bone turnover for prediction of fracture","volume":"94","author":"Johansson","year":"2014","journal-title":"Calcif Tissue Int."},{"key":"10.1016\/j.endonu.2016.06.004_bib0475","doi-asserted-by":"crossref","first-page":"E1740","DOI":"10.1210\/jc.2013-2264","article-title":"Traditional and novel bone remodeling markers in premenopausal and postmenopausal women","volume":"98","author":"Botella","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0480","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","article-title":"Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice","volume":"78","author":"Harvey","year":"2015","journal-title":"Bone."},{"key":"10.1016\/j.endonu.2016.06.004_bib0485","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00198-014-2704-7","article-title":"Bone quality assessment in type 2 diabetes mellitus","volume":"25","author":"Dhaliwal","year":"2014","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.endonu.2016.06.004_bib0490","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/jc.2012-3118","article-title":"TBS (trabecular bone score) and diabetes-related fracture risk","volume":"98","author":"Leslie","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0495","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1210\/jc.2014-2047","article-title":"Trabecular bone score as an indicator for skeletal deterioration in diabetes","volume":"100","author":"Kim","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2016.06.004_bib0500","first-page":"e47","article-title":"Update of recommendations for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions. Working Group on Osteoporosis and Mineral Metabolism of the Spanish Society of Endocrinology","volume":"62","author":"Reyes-Garcia","year":"2015","journal-title":"Endocrinol Nutr."}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092216300912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092216300912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T18:50:27Z","timestamp":1536346227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092216300912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1575092216300912"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2016.06.004","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La paradoja diab\u00e9tica: densidad mineral \u00f3sea y fractura en la diabetes tipo 2","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endonu.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SEEN. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}